Trademark applications and grants for Genetech Inc. Genetech Inc has 1 trademark applications. The latest application filed is for "SYNERGIS"
Patent Application | Date |
---|---|
PROCESS FOR MAKING HYDROXYLATED CYCLOPENTYLPYRIMIDINE COMPOUNDS 20150099881 - 14/401091 Lane; Jonathan W. ;   et al. | 2015-04-09 |
PROCESS OF MAKING HYDROXYLATED CYCLOPENTAPYRIMIDINE COMPOUNDS AND SALTS THEREOF 20150099880 - 14/401089 Babu; Srinivasan ;   et al. | 2015-04-09 |
MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER 20140044706 - 13/912281 Belvin; Marcia ;   et al. | 2014-02-13 |
HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES 20140018368 - 13/932395 Cai; Xiong ;   et al. | 2014-01-16 |
SERINE/THREONINE KINASE INHIBITORS 20130338140 - 14/002079 Blake; James F. ;   et al. | 2013-12-19 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "SYNERGIS" 78965677 |
SYNERGIS 2006-09-01 |
NCAGE Code | 1FJ96 | GENETECH INC |
CAGE Code | 1FJ96 | GENETECH INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.